6505--Dutasteride Capsules
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The VA National Acquisition Center has issued a Pre-Solicitation Notice for RFP 36E79726R0029, an unrestricted procurement for Dutasteride 0.5MG Capsules. This opportunity aims to secure an uninterrupted supply for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The solicitation is anticipated to be released around June 22, 2026, with a tentative closing date of July 7, 2026.
Purpose & Scope
The successful offeror will provide an uninterrupted source of supply for Dutasteride 0.5MG Capsules. Estimated annual requirements include 3,912 bottles of 30-count and 25,502 bottles of 90-count.
Key Requirements
- Offerors must state the exact drug name (as it appears on the label) and possess a unique NDC number.
- The successful offeror's label with its unique NDC shall be the only label on the product; no overlaying of labels is permitted.
- Unit of use packaging (30 and 90 count bottles) must include a safety-cap (deshellable or convertible) and a bottle with a minimum 120cc volume, 5.75" circumference, and a cylindrical body.
- The bottle must accommodate a 5.25" x 2" label, with an additional 0.5" space required for barcode and/or expiration date/lot number display.
Contract Details
- Type: Commercial item format, in accordance with FAR Part 12.
- Duration: One base year plus four pre-priced one-year option periods.
- Distribution: Through the VA’s and DoD’s respective Pharmaceutical Prime Vendor Programs.
- Set-Aside: Unrestricted.
- NAICS Code: 325412.
Submission & Timeline
- Solicitation Release: Electronically issued on or about June 22, 2026.
- Proposal Due: Tentatively July 7, 2026, 2:30 PM Central Time.
- Method: All future amendments and documents will be available electronically for download at SAM.gov. Offerors must continuously check SAM.gov for updates.
- Point of Contact: Richard Mahario, Contract Specialist, at Richard.Mahario@va.gov or 708-786-5247.